The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil
oleh: Leonardo Zumerkorn Pipek, João Vitor Mahler, Rafaela Farias Vidigal Nascimento, Jefferson Becker, Samira Luísa Apóstolos-Pereira, Tarso Adoni, Guilherme Diogo Silva, Dagoberto Callegaro, on behalf of BCTRIMS (Comitê Brasileiro de Pesquisa e Tratamento em Esclerose Múltipla)
| Format: | Article |
|---|---|
| Diterbitkan: | Academia Brasileira de Neurologia (ABNEURO) 2024-01-01 |
Deskripsi
No description available for this item.